Trial Profile
The effects of ivabradine on heart rate in patients with ST-elevated myocardial infarction who underwent percutaneous coronary intervention
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2021
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Myocardial infarction
- Focus Pharmacodynamics
- Acronyms VIVIFY
- 13 Oct 2008 New trial record.